Nasal immunization with mannan-decorated mucoadhesive HPMCP microspheres containing ApxIIA toxin induces protective immunity against challenge infection with Actinobacillus pleuropneumoiae in mice.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Journal of Controlled Release

• Publication date

  2016-07-10

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.jconrel.2016.05.032PMID 27189136
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Attuning hydroxypropyl methylcellulose phthalate to oral delivery vehicle for effective and selective delivery of protein vaccine in ileum.

  2015cited by this paper
• Nasal immunization with M cell-targeting ligand-conjugated ApxIIA toxin fragment induces protective immunity against Actinobacillus pleuropneumoniae infection in a murine model.

  2015cited by this paper
• Mannosylated poly(beta-amino esters) for targeted antigen presenting cell immune modulation.

  2015cited by this paper
• Development of a novel adjuvanted nasal vaccine: C48/80 associated with chitosan nanoparticles as a path to enhance mucosal immunity.

  2015cited by this paper
• Recombinant interleukin 6 with M cell-targeting moiety produced in Lactococcus lactis IL1403 as a potent mucosal adjuvant for peroral immunization.

  2015cited by this paper
• Targeted oral delivery of BmpB vaccine using porous PLGA microparticles coated with M cell homing peptide-coupled chitosan.

  2014cited by this paper
• Nasal immunity is an ancient arm of the mucosal immune system of vertebrates

  2014cited by this paper
• Development and characterization of surface modified PLGA nanoparticles for nasal vaccine delivery: effect of mucoadhesive coating on antigen uptake and immune adjuvant activity.

  2013cited by this paper
• Nasal immunization with major epitope-containing ApxIIA toxin fragment induces protective immunity against challenge infection with Actinobacillus pleuropneumoniae in a murine model.

  2013cited by this paper
• Co-delivery of viral proteins and a TLR7 agonist from polysaccharide nanocapsules: a needle-free vaccination strategy.

  2013cited by this paper
• Protective Humoral Immunity Elicited by a Needle-Free Malaria Vaccine Comprised of a Chimeric Plasmodium falciparum Circumsporozoite Protein and a Toll-Like Receptor 5 Agonist, Flagellin

  2013cited by this paper
• Tailoring the immune response by targeting C-type lectin receptors on alveolar macrophages using "pathogen-like" amphiphilic polyanhydride nanoparticles.

  2012cited by this paper
• Comparison of antibodies and carbohydrates to target vaccines to human dendritic cells via DC-SIGN.

  2012cited by this paper
• Recent progress in mucosal vaccine development: potential and limitations

  2012cited by this paper
• Generation of transgenic corn-derived Actinobacillus pleuropneumoniae ApxIIA fused with the cholera toxin B subunit as a vaccine candidate

  2011cited by this paper
• An immunosorbent assay based on the recombinant ApxIa, ApxIIa, and ApxIIIa toxins of Actinobacillus pleuropneumoniae and its application to field sera

  2011cited by this paper
• Microencapsulation of Vaccine Antigens and Adjuvants for Mucosal Targeting

  2010cited by this paper
• Nanogel antigenic protein-delivery system for adjuvant-free intranasal vaccines.

  2010cited by this paper
• Influence of Particle Size and Material Properties on Mucociliary Clearance from the Airways

  2010cited by this paper
• Immunoadjuvant capacity of flagellin and mannosamine-coated poly(anhydride) nanoparticles in oral vaccination.

  2009cited by this paper
• The macrophage mannose receptor induces IL-17 in response to Candida albicans.

  2009cited by this paper
• The potential of mannosylated chitosan microspheres to target macrophage mannose receptors in an adjuvant-delivery system for intranasal immunization.

  2008cited by this paper
• Role of Particle Size in Phagocytosis of Polymeric Microspheres

  2008cited by this paper
• pH-sensitive and mucoadhesive thiolated Eudragit-coated chitosan microspheres.

  2008cited by this paper
• Immunological properties of engineered nanomaterials

  2007cited by this paper
• Mucociliary and long-term particle clearance in airways of patients with immotile cilia

  2006cited by this paper
• Modified Pulmonary Surfactant Is a Potent Adjuvant That Stimulates the Mucosal IgA Production in Response to the Influenza Virus Antigen1

  2006cited by this paper
• Regional lung deposition and bronchodilator response as a function of beta2-agonist particle size.

  2005cited by this paper
• Regional Lung Deposition and Bronchodilator Response as a Function of β2-Agonist Particle Size

  2005cited by this paper
• Induction of antigen-specific immune responses by oral vaccination with Saccharomyces cerevisiae expressing Actinobacillus pleuropneumoniae ApxIIA.

  2005cited by this paper
• Thiomers: potential excipients for non-invasive peptide delivery systems.

  2004cited by this paper
• Mannose receptor-targeted vaccines

  2004cited by this paper
• Role of IgA versus IgG in the Control of Influenza Viral Infection in the Murine Respiratory Tract1

  2004cited by this paper
• Oxidised mannan-listeriolysin O conjugates induce Th1/Th2 cytokine responses after intranasal immunisation.

  2002cited by this paper
• Oxidised mannan as a novel adjuvant inducing mucosal IgA production.

  2002cited by this paper
• Thiolated polymers: synthesis and in vitro evaluation of polymer-cysteamine conjugates.

  2001cited by this paper
• Nasal delivery of octreotide: Absorption enhancement by particulate carrier systems

  1996cited by this paper

• Chitosan and mannose-modified dual-functional mRNA-LNP vaccines for robust systemic and mucosal immune responses.

  2025cites this paper
• Intranasal delivery systems for traumatic brain injury: Advancements and perspectives

  2025cites this paper
• NLP Analysis of Mannan-Based Drug Delivery Trends

  2025cites this paper
• The review of nasal drug delivery system: The strategies to enhance the efficiency of intranasal drug delivery by improving drug absorption.

  2025cites this paper
• Polysaccharide nanoparticles as potential immune adjuvants: Mechanism and function

  2025cites this paper
• Modified PEG-Lipids Enhance the Nasal Mucosal Immune Capacity of Lipid Nanoparticle mRNA Vaccines

  2024cites this paper
• Tumor‐Targeted Catalytic Immunotherapy

  2024cites this paper
• Mannosylated preactivated hyaluronic acid-based nanostructures for bacterial infection treatment.

  2023cites this paper
• An updated review on oral protein-based antigen vaccines efficiency and delivery approaches: a special attention to infectious diseases

  2023cites this paper
• The Role of Mucoadhesion and Mucopenetration in the Immune Response Induced by Polymer-Based Mucosal Adjuvants

  2023cites this paper
• Recent advances on drug delivery applications of mucopenetrative/mucoadhesive particles: A review

  2022cites this paper
• Towards the future exploration of mucosal mRNA vaccines against emerging viral diseases; lessons from existing next-generation mucosal vaccine strategies

  2022cites this paper
• Mannose in vaccine delivery.

  2022cites this paper
• Towards the future exploration of mucosal mRNA vaccines against emerging viral diseases; lessons from existing next-generation mucosal vaccine strategies

  2022cites this paper
• Nanotechnologies for intranasal drug delivery: an update of literature

  2021cites this paper
• Effects on immunization of the physicochemical parameters of particles as vaccine carriers.

  2021cites this paper
• Intranasal Vaccine Delivery Technology for Respiratory Tract Disease Application with a Special Emphasis on Pneumococcal Disease

  2021cites this paper
• Mucosal Vaccine Delivery Using Mucoadhesive Polymer Particulate Systems

  2021cites this paper
• Application of Mannose‐Functionalized Microgel as a Novel Vaccine Delivery Platform for Subunit Vaccines

  2021cites this paper
• Site-specific MOF-based immunotherapeutic nanoplatforms via synergistic tumor cells-targeted treatment and dendritic cells-targeted immunomodulation.

  2020cites this paper
• Induction of systemic immunity through nasal-associated lymphoid tissue (NALT) of mice intranasally immunized with Brucella abortus malate dehydrogenase-loaded chitosan nanoparticles

  2020cites this paper
• Mucoadhesive delivery systems for nanoencapsulated food ingredients

  2020cites this paper
• Improving hypoglycemic effect of insulin via the nasal administration of deep eutectic solvents.

  2019cites this paper
• Induction of Th2-related immune responses and production of systemic IgA in mice intranasally immunized with Brucella abortus malate dehydrogenase loaded chitosan nanoparticles.

  2019cites this paper
• Efficient Mucosal Immunization by Mucoadhesive and pH-Sensitive Polymeric Vaccine Delivery System

  2019cites this paper
• Enhanced Efficacy of Immunization with a Foot-and-Mouth Disease Multi-Epitope Subunit Vaccine Using Mannan-Decorated Inulin Microparticles

  2019cites this paper
• Elicitation of Th1/Th2 related responses in mice by chitosan nanoparticles loaded with Brucella abortus malate dehydrogenase, outer membrane proteins 10 and 19.

  2019cites this paper
• New trends in innovative vaccine development against Actinobacillus pleuropneumoniae.

  2018cites this paper
• Albumin and IgG Removal by Cellulose Biosorbents

  2017cites this paper
• Actinobacillus pleuropneumoniae biofilms: Role in pathogenicity and potential impact for vaccination development

  2017influential citation
• A critical review about methodologies for the analysis of mucoadhesive properties of drug delivery systems

  2017cites this paper
• Intranasal Vaccination with Mannosylated Chitosan Formulated DNA Vaccine Enables Robust IgA and Cellular Response Induction in the Lungs of Mice and Improves Protection against Pulmonary Mycobacterial Challenge

  2017cites this paper
• Sulfonate-modified phenylboronic acid-rich nanoparticles as a novel mucoadhesive drug delivery system for vaginal administration of protein therapeutics: improved stability, mucin-dependent release and effective intravaginal placement

  2016cites this paper
• Immunoprotective Efficacy of Six In vivo-Induced Antigens against Actinobacillus pleuropneumoniae as Potential Vaccine Candidates in Murine Model

  2016cites this paper